Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000731727 | SCV000859576 | uncertain significance | not provided | 2018-02-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002535237 | SCV003261561 | likely benign | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2024-06-26 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004535850 | SCV004713913 | uncertain significance | CC2D2A-related disorder | 2024-01-18 | no assertion criteria provided | clinical testing | The CC2D2A c.349A>G variant is predicted to result in the amino acid substitution p.Thr117Ala. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0046% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/4-15482447-A-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |